Skip to content

Interest Income at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$4M+33.3%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$229M-31.0%
Henry Schein logo
Henry ScheinHSIC
$7M+16.7%
Abbott logo
AbbottABT
$106M+29.3%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$6.05M+58.1%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$6.25M+16.0%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.86B-15.9%

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's interest income?
Bausch Health Companies (BHC) reported interest income of $10M in Q1 2026.
How has Bausch Health Companies's interest income changed year-over-year?
Bausch Health Companies's interest income decreased by 9.1% year-over-year, from $11M to $10M.
What is the long-term trend for Bausch Health Companies's interest income?
Over 4 years (2021 to 2025), Bausch Health Companies's interest income has grown at a 61.8% compound annual growth rate (CAGR), from $7M to $48M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.